首页 > 最新文献

BMC Pediatrics最新文献

英文 中文
Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial. 评估富含生育三烯酚的维生素 E 部分对患有非酒精性脂肪肝的肥胖儿童的疗效:单盲随机临床试验。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-20 DOI: 10.1186/s12887-024-04993-8
Farah D R Al-Baiaty, Shareena Ishak, Faizah Mohd Zaki, Farin Masra, Dayang Anita Abdul Aziz, Wan Nurulhuda Wan Md Zin, Erica Yee Hing, Azrina Syarizad Kuthubul Zaman, Norhazlina Abdul Wahab, Khairul Najmi Muhammad Nawawi, Zalina Hamid, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar

Background: Childhood obesity is a growing concern, and non-alcoholic fatty liver disease (NAFLD) is a significant consequence. Currently, there are no approved drugs to treat NAFLD in children. However, a recent study explored the potential of vitamin E enriched with tocotrienol (TRF) as a powerful antioxidant for NAFLD. The aims of the present study were to investigate the effectiveness and safety of TRF in managing children with obesity and NAFLD.

Methods: A total of 29 patients aged 10 to 18 received a daily oral dose of 50 mg TRF for six months (January 2020 to February 2022), and all had fatty liver disease were detected by ultrasonography and abnormally high alanine transaminase levels (at least two-fold higher than the upper limits for their respective genders). Various parameters, including biochemical markers, FibroScan, LiverFASt, DNA damage, and cytokine expression, were monitored.

Results: APO-A1 and AST levels decreased significantly from 1.39 ± 0.3 to 1.22 ± 0.2 g/L (P = 0.002) and from 30 ± 12 to 22 ± 10 g/L (P = 0.038), respectively, in the TRF group post-intervention. Hepatic steatosis was significantly reduced in the placebo group from 309.38 ± 53.60 db/m to 277.62 ± 39.55 db/m (p = 0.048), but not in the TRF group. Comet assay analysis showed a significant reduction in the DNA damage parameters in the TRF group in the post-intervention period compared to the baseline, with tail length decreasing from 28.34 ± 10.9 to 21.69 ± 9.84; (p = 0.049) and with tail DNA (%) decreasing from 54.13 ± 22.1to 46.23 ± 17.9; (p = 0.043). Pro-inflammatory cytokine expression levels were significantly lower in the TRF group compared to baseline levels for IL-6 (2.10 6.3 to 0.7 1.0 pg/mL; p = 0.047 pg/mL) and TNF-1 (1.73 5.5 pg/mL to 0.7 0.5 pg/mL; p = 0.045).

Conclusion: The study provides evidence that TRF supplementation may offer a risk-free treatment option for children with obesity and NAFLD. The antioxidant and anti-inflammatory properties of TRF offer a promising adjuvant therapy for NAFLD treatment. In combination with lifestyle modifications such as exercise and calorie restriction, TRF could play an essential role in the prevention of NAFLD in the future. However, further studies are needed to explore the long-term effects of TRF supplementation on NAFLD in children.

Trial registration: The study has been registered with the International Clinical Trial Registry under reference number (NCT05905185) retrospective registration on (15/06/2023).

背景:儿童肥胖症日益引起人们的关注,而非酒精性脂肪肝(NAFLD)则是肥胖症的一个重要后果。目前,治疗儿童非酒精性脂肪肝的药物尚未获得批准。然而,最近的一项研究探索了富含生育三烯酚(TRF)的维生素E作为一种强效抗氧化剂治疗非酒精性脂肪肝的潜力。本研究旨在探讨 TRF 在治疗肥胖和非酒精性脂肪肝儿童中的有效性和安全性:共有29名10至18岁的患者接受了为期6个月(2020年1月至2022年2月)、每天口服50毫克TRF的治疗,所有患者均通过超声波检查发现患有脂肪肝,且丙氨酸转氨酶水平异常偏高(比各自性别的上限至少高出2倍)。对包括生化指标、FibroScan、LiverFASt、DNA 损伤和细胞因子表达在内的各种参数进行了监测:结果:干预后,TRF 组的 APO-A1 和 AST 水平分别从 1.39 ± 0.3 克/升(P = 0.002)和 30 ± 12 克/升(P = 0.038)显著降至 1.22 ± 0.2 克/升(P = 0.002)和 22 ± 10 克/升(P = 0.038)。安慰剂组的肝脏脂肪变性从 309.38 ± 53.60 db/m 显著降至 277.62 ± 39.55 db/m (P = 0.048),而 TRF 组则没有。彗星测定分析显示,与基线相比,干预后 TRF 组的 DNA 损伤参数显著减少,尾长从 28.34 ± 10.9 降至 21.69 ± 9.84;(p = 0.049),尾部 DNA(%)从 54.13 ± 22.1 降至 46.23 ± 17.9;(p = 0.043)。与基线水平相比,TRF组的促炎细胞因子表达水平明显降低,其中IL-6(2.10 6.3 pg/mL至0.7 1.0 pg/mL;p = 0.047 pg/mL)和TNF-1(1.73 5.5 pg/mL至0.7 0.5 pg/mL;p = 0.045):本研究提供的证据表明,补充 TRF 可为肥胖和非酒精性脂肪肝患儿提供一种无风险的治疗选择。TRF的抗氧化和抗炎特性为治疗非酒精性脂肪肝提供了一种前景广阔的辅助疗法。结合运动和限制热量等生活方式的调整,TRF在未来预防非酒精性脂肪肝方面可能发挥重要作用。不过,还需要进一步研究补充TRF对儿童非酒精性脂肪肝的长期影响:该研究已在国际临床试验注册中心注册,注册编号为(NCT05905185),注册日期为(15/06/2023)。
{"title":"Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial.","authors":"Farah D R Al-Baiaty, Shareena Ishak, Faizah Mohd Zaki, Farin Masra, Dayang Anita Abdul Aziz, Wan Nurulhuda Wan Md Zin, Erica Yee Hing, Azrina Syarizad Kuthubul Zaman, Norhazlina Abdul Wahab, Khairul Najmi Muhammad Nawawi, Zalina Hamid, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar","doi":"10.1186/s12887-024-04993-8","DOIUrl":"10.1186/s12887-024-04993-8","url":null,"abstract":"<p><strong>Background: </strong>Childhood obesity is a growing concern, and non-alcoholic fatty liver disease (NAFLD) is a significant consequence. Currently, there are no approved drugs to treat NAFLD in children. However, a recent study explored the potential of vitamin E enriched with tocotrienol (TRF) as a powerful antioxidant for NAFLD. The aims of the present study were to investigate the effectiveness and safety of TRF in managing children with obesity and NAFLD.</p><p><strong>Methods: </strong>A total of 29 patients aged 10 to 18 received a daily oral dose of 50 mg TRF for six months (January 2020 to February 2022), and all had fatty liver disease were detected by ultrasonography and abnormally high alanine transaminase levels (at least two-fold higher than the upper limits for their respective genders). Various parameters, including biochemical markers, FibroScan, LiverFASt, DNA damage, and cytokine expression, were monitored.</p><p><strong>Results: </strong>APO-A1 and AST levels decreased significantly from 1.39 ± 0.3 to 1.22 ± 0.2 g/L (P = 0.002) and from 30 ± 12 to 22 ± 10 g/L (P = 0.038), respectively, in the TRF group post-intervention. Hepatic steatosis was significantly reduced in the placebo group from 309.38 ± 53.60 db/m to 277.62 ± 39.55 db/m (p = 0.048), but not in the TRF group. Comet assay analysis showed a significant reduction in the DNA damage parameters in the TRF group in the post-intervention period compared to the baseline, with tail length decreasing from 28.34 ± 10.9 to 21.69 ± 9.84; (p = 0.049) and with tail DNA (%) decreasing from 54.13 ± 22.1to 46.23 ± 17.9; (p = 0.043). Pro-inflammatory cytokine expression levels were significantly lower in the TRF group compared to baseline levels for IL-6 (2.10 6.3 to 0.7 1.0 pg/mL; p = 0.047 pg/mL) and TNF-1 (1.73 5.5 pg/mL to 0.7 0.5 pg/mL; p = 0.045).</p><p><strong>Conclusion: </strong>The study provides evidence that TRF supplementation may offer a risk-free treatment option for children with obesity and NAFLD. The antioxidant and anti-inflammatory properties of TRF offer a promising adjuvant therapy for NAFLD treatment. In combination with lifestyle modifications such as exercise and calorie restriction, TRF could play an essential role in the prevention of NAFLD in the future. However, further studies are needed to explore the long-term effects of TRF supplementation on NAFLD in children.</p><p><strong>Trial registration: </strong>The study has been registered with the International Clinical Trial Registry under reference number (NCT05905185) retrospective registration on (15/06/2023).</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between abnormal sleep behavior and indoor environmental risk factors among children with a chronic cough in Wuxi, China: a cross-sectional study. 中国无锡慢性咳嗽患儿异常睡眠行为与室内环境风险因素之间的关系:一项横断面研究。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-20 DOI: 10.1186/s12887-024-04876-y
Shiyao Xu, Zhenzhen Pan, Yun Guo, Qin Zhou, Qian Wang, Shanshan Pan, Ling Li

Background: Indoor environmental factors, such as pet ownership, presence of cockroaches, mattress quality, fuel usage (gas or electricity), use of biomass for cooking and heating, exposure to tobacco smoke or household molds can significantly affect the sleep quality of children with chronic cough. However, data regarding the effects of indoor environmental conditions on sleep in this population are limited. This study aimed to assess the prevalence of abnormal sleep behaviors and to establish associations between indoor environmental factors and sleep behaviors among children with chronic cough in Wuxi, China.

Methods: A cross-sectional design was employed in this study, involving children aged 3-18 years. Data on sociodemographic factors, allergies, home environmental exposures, and sleep characteristics of the participants were collected using paper-based questionnaires. The association between indoor environmental factors and sleep behaviors in children with chronic cough was analyzed using logistic regression models.

Results: The findings demonstrated that the prevalence of chronic cough among children in Wuxi was 15.50%. The chronic cough group exhibited a significantly higher incidence of eczema, wheezing, rhinitis, food allergy, and nasosinusitis than the non-chronic cough group. In addition, children with chronic cough also tended to have a family history of sleep disorders and adenoid hypertrophy (P < 0.01). After adjusting for confounding factors, a significant association was observed between bruxism (teeth grinding) and chronic cough (sometimes: odds ratio [OR] = 1.04; confidence interval [CI] = 1.01-1.08; always: OR = 1.11; CI = 1.04-1.19; P < 0.01). Among children with chronic cough, recent home decoration was associated with sleepwalking (OR = 1.04; CI = 1.00-1.07; P < 0.05), mold exposure was associated with bruxism (OR = 1.15; CI = 1.0-1.31; P < 0.05), and carpet use at home was associated with apnea (OR = 1.09; CI = 1.02-1.17; P < 0.05), twitching during sleep (OR = 1.13; CI = 1.00-1.27; P < 0.01) and morning headache (OR = 1.14; CI = 1.05-1.23; P < 0.01).

Conclusion: Children with chronic cough are more prone to some abnormal sleep behaviors than children without chronic cough. Household decoration within a year, household mold exposure, and carpet use were all significantly positively associated with abnormal sleep behaviors in children with chronic cough. Our study provides novel insights into the impact of the indoor environment on children's sleep and the occurrence of chronic cough, offering guidance for tailored health promotion programs for families.

背景:室内环境因素,如饲养宠物、是否有蟑螂、床垫质量、燃料使用(煤气或电力)、使用生物质做饭和取暖、接触烟草烟雾或家庭霉菌等,都会严重影响慢性咳嗽患儿的睡眠质量。然而,有关室内环境条件对这类人群睡眠影响的数据却很有限。本研究旨在评估无锡慢性咳嗽患儿异常睡眠行为的发生率,并建立室内环境因素与睡眠行为之间的关联:本研究采用横断面设计,涉及 3-18 岁的儿童。通过纸质问卷收集了参与者的社会人口学因素、过敏症、家庭环境暴露和睡眠特征等数据。研究采用逻辑回归模型分析了室内环境因素与慢性咳嗽儿童睡眠行为之间的关系:结果:研究结果表明,无锡市儿童慢性咳嗽的患病率为 15.50%。慢性咳嗽组湿疹、喘息、鼻炎、食物过敏和鼻窦炎的发病率明显高于非慢性咳嗽组。此外,慢性咳嗽患儿还往往有睡眠障碍和腺样体肥大的家族史(P 结论:慢性咳嗽患儿更容易患睡眠障碍和腺样体肥大:与非慢性咳嗽儿童相比,慢性咳嗽儿童更容易出现一些异常睡眠行为。一年内的家庭装修、家庭霉菌暴露和地毯使用均与慢性咳嗽儿童的异常睡眠行为呈显著正相关。我们的研究为室内环境对儿童睡眠和慢性咳嗽发生的影响提供了新的见解,为为家庭量身定制健康促进计划提供了指导。
{"title":"Associations between abnormal sleep behavior and indoor environmental risk factors among children with a chronic cough in Wuxi, China: a cross-sectional study.","authors":"Shiyao Xu, Zhenzhen Pan, Yun Guo, Qin Zhou, Qian Wang, Shanshan Pan, Ling Li","doi":"10.1186/s12887-024-04876-y","DOIUrl":"10.1186/s12887-024-04876-y","url":null,"abstract":"<p><strong>Background: </strong>Indoor environmental factors, such as pet ownership, presence of cockroaches, mattress quality, fuel usage (gas or electricity), use of biomass for cooking and heating, exposure to tobacco smoke or household molds can significantly affect the sleep quality of children with chronic cough. However, data regarding the effects of indoor environmental conditions on sleep in this population are limited. This study aimed to assess the prevalence of abnormal sleep behaviors and to establish associations between indoor environmental factors and sleep behaviors among children with chronic cough in Wuxi, China.</p><p><strong>Methods: </strong>A cross-sectional design was employed in this study, involving children aged 3-18 years. Data on sociodemographic factors, allergies, home environmental exposures, and sleep characteristics of the participants were collected using paper-based questionnaires. The association between indoor environmental factors and sleep behaviors in children with chronic cough was analyzed using logistic regression models.</p><p><strong>Results: </strong>The findings demonstrated that the prevalence of chronic cough among children in Wuxi was 15.50%. The chronic cough group exhibited a significantly higher incidence of eczema, wheezing, rhinitis, food allergy, and nasosinusitis than the non-chronic cough group. In addition, children with chronic cough also tended to have a family history of sleep disorders and adenoid hypertrophy (P < 0.01). After adjusting for confounding factors, a significant association was observed between bruxism (teeth grinding) and chronic cough (sometimes: odds ratio [OR] = 1.04; confidence interval [CI] = 1.01-1.08; always: OR = 1.11; CI = 1.04-1.19; P < 0.01). Among children with chronic cough, recent home decoration was associated with sleepwalking (OR = 1.04; CI = 1.00-1.07; P < 0.05), mold exposure was associated with bruxism (OR = 1.15; CI = 1.0-1.31; P < 0.05), and carpet use at home was associated with apnea (OR = 1.09; CI = 1.02-1.17; P < 0.05), twitching during sleep (OR = 1.13; CI = 1.00-1.27; P < 0.01) and morning headache (OR = 1.14; CI = 1.05-1.23; P < 0.01).</p><p><strong>Conclusion: </strong>Children with chronic cough are more prone to some abnormal sleep behaviors than children without chronic cough. Household decoration within a year, household mold exposure, and carpet use were all significantly positively associated with abnormal sleep behaviors in children with chronic cough. Our study provides novel insights into the impact of the indoor environment on children's sleep and the occurrence of chronic cough, offering guidance for tailored health promotion programs for families.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical, pathological and genetic characteristics of 17 unrelated children with Alagille Syndrome. 17 名患有阿拉吉尔综合征的无血缘关系儿童的临床、病理和遗传特征。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-20 DOI: 10.1186/s12887-024-04973-y
Jianguo Yan, Yuanzhi Huang, Lili Cao, Yi Dong, Zhiqiang Xu, Fuchuan Wang, Yinjie Gao, Danni Feng, Min Zhang

Background: Alagille syndrome (ALGS) is a multisystem genetic disorder frequently characterized by hepatic manifestations. This study analyzed the clinical, pathological, and molecular genetic features of ALGS to improve the efficiency of clinical diagnosis.

Methods: We retrospectively analyzed the clinical manifestations, pathological examination findings, and genetic testing results of 17 children diagnosed with ALGS based on the revised criteria and hospitalized at our center from January 2012 to January 2022.

Results: The clinical manifestations are as follows: Cholestasis (16/17, 94%), characteristic facies (15/17, 88%), heart disease (12/16, 75%), butterfly vertebrae (12/17, 71%) and posterior embryotoxon (7/12, 58%). Among the 15 patients who underwent liver pathology examination, 13 (87%) were found to have varying degrees of bile duct paucity. Genetic testing was performed on 15 children, and pathogenic variants of the jagged canonical Notch ligand 1 (JAG1) gene were identified in 13 individuals, including 4 novel variants. No pathogenic variant in the notch homolog 2 (NOTCH2) gene were identified, and 2 children exhibited none of the aforementioned gene pathogenic variants. The median follow-up duration was 7 years. Of the remaining 15 patients (excluding 2 lost to follow-up), 11 remained stable, 4 deteriorated, and no patient died during the follow-up period.

Conclusions: Among children diagnosed with ALGS, cholestasis stands as the most common feature. To minimize the risk of misdiagnosis, genetic testing should be performed on children exhibiting cholestasis, followed by the application of the revised diagnostic criteria for ALGS. While pharmacological therapy has shown effectiveness for ALGS patients, liver transplantation may be considered in instances of severe pruritus.

背景:阿拉吉尔综合征(ALGS)是一种多系统遗传性疾病,常以肝脏表现为特征。本研究分析了 ALGS 的临床、病理和分子遗传特征,以提高临床诊断的效率:我们回顾性分析了2012年1月至2022年1月根据修订标准确诊为ALGS并在本中心住院治疗的17名儿童的临床表现、病理检查结果和基因检测结果:临床表现如下胆汁淤积(16/17,94%)、特征性面容(15/17,88%)、心脏病(12/16,75%)、蝶形脊椎(12/17,71%)和后胚胎毒(7/12,58%)。在接受肝脏病理检查的 15 名患者中,有 13 人(87%)被发现患有不同程度的胆管缺失。对15名患儿进行了基因检测,在13人中发现了炯炯有神的Notch配体1(JAG1)基因的致病变体,其中包括4个新型变体。没有发现缺口同源物 2(NOTCH2)基因的致病变体,2 名儿童没有表现出上述任何一种基因致病变体。中位随访时间为 7 年。其余15名患者(不包括2名失去随访的患者)中,11人病情保持稳定,4人病情恶化,没有患者在随访期间死亡:结论:在确诊为ALGS的儿童中,胆汁淤积是最常见的特征。结论:在被诊断为 ALGS 的儿童中,胆汁淤积症是最常见的特征。为了最大限度地降低误诊风险,应对出现胆汁淤积症的儿童进行基因检测,然后应用 ALGS 的修订诊断标准。虽然药物治疗对 ALGS 患者有效,但在严重瘙痒的情况下可考虑肝移植。
{"title":"Clinical, pathological and genetic characteristics of 17 unrelated children with Alagille Syndrome.","authors":"Jianguo Yan, Yuanzhi Huang, Lili Cao, Yi Dong, Zhiqiang Xu, Fuchuan Wang, Yinjie Gao, Danni Feng, Min Zhang","doi":"10.1186/s12887-024-04973-y","DOIUrl":"10.1186/s12887-024-04973-y","url":null,"abstract":"<p><strong>Background: </strong>Alagille syndrome (ALGS) is a multisystem genetic disorder frequently characterized by hepatic manifestations. This study analyzed the clinical, pathological, and molecular genetic features of ALGS to improve the efficiency of clinical diagnosis.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical manifestations, pathological examination findings, and genetic testing results of 17 children diagnosed with ALGS based on the revised criteria and hospitalized at our center from January 2012 to January 2022.</p><p><strong>Results: </strong>The clinical manifestations are as follows: Cholestasis (16/17, 94%), characteristic facies (15/17, 88%), heart disease (12/16, 75%), butterfly vertebrae (12/17, 71%) and posterior embryotoxon (7/12, 58%). Among the 15 patients who underwent liver pathology examination, 13 (87%) were found to have varying degrees of bile duct paucity. Genetic testing was performed on 15 children, and pathogenic variants of the jagged canonical Notch ligand 1 (JAG1) gene were identified in 13 individuals, including 4 novel variants. No pathogenic variant in the notch homolog 2 (NOTCH2) gene were identified, and 2 children exhibited none of the aforementioned gene pathogenic variants. The median follow-up duration was 7 years. Of the remaining 15 patients (excluding 2 lost to follow-up), 11 remained stable, 4 deteriorated, and no patient died during the follow-up period.</p><p><strong>Conclusions: </strong>Among children diagnosed with ALGS, cholestasis stands as the most common feature. To minimize the risk of misdiagnosis, genetic testing should be performed on children exhibiting cholestasis, followed by the application of the revised diagnostic criteria for ALGS. While pharmacological therapy has shown effectiveness for ALGS patients, liver transplantation may be considered in instances of severe pruritus.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a nomogram for catheter-related thrombosis prediction in children with central venous catheter: a retrospective observational study. 使用中心静脉导管的儿童导管相关血栓预测提名图的开发与验证:一项回顾性观察研究。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-20 DOI: 10.1186/s12887-024-05008-2
Wangfang Xie, Bin Xu, Xiaofang Lou, Jihua Zhu, Sheng Ye

Background: Catheter-related thrombosis (CRT) is a thrombotic complication associated with using central venous catheters (CVCs). Although risk factors for CRT were identified in children, no nomograms or predictive tools are available for the pediatric population with CVCs. This study aimed to develop and validate a prediction model of asymptomatic CRT in children with CVCs.

Methods: This retrospective observational study included consecutive pediatric patients who admitted to the Children's Hospital Zhejiang University School of Medicine and received CVCs between October and December 2021.

Results: This study included 669 patients, 553 (314 males, aged 22.00 [0.36, 180.00] months, 62 with CRT) were in the training set, and 116 (62 males, aged 15.00 [1.13, 156.00] months, 16 with CRT) were in the validation set. Multivariate logistic regression showed that a catheter time of 0-3 days (OR = 0.201, 95%CI: 0.081-0.497, P = 0.001), catheter time of 4-7 days (OR = 0.412, 95%CI: 0.176-0.964, P = 0.041), male (OR = 3.976, 95%CI: 1.864-4.483, P < 0.001), congenital heart diseases (OR = 0.277, 95%CI: 0.078-0.987, P = 0.048), postoperative (OR = 0.161, 95%CI: 0.072-0.360, P < 0.001), and femoral CVC (OR = 2.451, 95%CI: 1.129-5.318, P = 0.002) were independently associated with CRT. The nomogram incorporating these variables showed relatively good discrimination (AUC = 0.77, 95%CI: [0.65, 0.90]) and calibration abilities in the validation set, and the decision curve analysis (DCA) yielded a clinical net benefit.

Conclusion: A prediction model for CRT in children with CVC was established based on catheter time, sex, diseases, postoperative, and catheter vein. The nomogram based on logistic regression model showed favorable predictive performance.

背景:导管相关血栓 (CRT) 是与使用中心静脉导管 (CVC) 相关的血栓并发症。虽然在儿童中发现了 CRT 的风险因素,但没有针对使用 CVC 的儿童群体的提名图或预测工具。本研究旨在开发并验证使用 CVC 的儿童无症状 CRT 预测模型:这项回顾性观察研究纳入了 2021 年 10 月至 12 月期间入住浙江大学医学院附属儿童医院并接受 CVC 的连续儿科患者:该研究共纳入669例患者,其中553例(314例男性,年龄22.00 [0.36, 180.00]个月,62例CRT患者)为训练集,116例(62例男性,年龄15.00 [1.13, 156.00]个月,16例CRT患者)为验证集。多变量逻辑回归显示,导管插入时间为 0-3 天(OR = 0.201,95%CI:0.081-0.497,P = 0.001)、导管插入时间为 4-7 天(OR = 0.412,95%CI:0.176-0.964,P = 0.041)、男性(OR = 3.976,95%CI:1.864-4.483,P 结论:根据导管时间、性别、疾病、术后情况和导管静脉,建立了CVC患儿CRT的预测模型。基于逻辑回归模型的提名图显示出良好的预测性能。
{"title":"Development and validation of a nomogram for catheter-related thrombosis prediction in children with central venous catheter: a retrospective observational study.","authors":"Wangfang Xie, Bin Xu, Xiaofang Lou, Jihua Zhu, Sheng Ye","doi":"10.1186/s12887-024-05008-2","DOIUrl":"10.1186/s12887-024-05008-2","url":null,"abstract":"<p><strong>Background: </strong>Catheter-related thrombosis (CRT) is a thrombotic complication associated with using central venous catheters (CVCs). Although risk factors for CRT were identified in children, no nomograms or predictive tools are available for the pediatric population with CVCs. This study aimed to develop and validate a prediction model of asymptomatic CRT in children with CVCs.</p><p><strong>Methods: </strong>This retrospective observational study included consecutive pediatric patients who admitted to the Children's Hospital Zhejiang University School of Medicine and received CVCs between October and December 2021.</p><p><strong>Results: </strong>This study included 669 patients, 553 (314 males, aged 22.00 [0.36, 180.00] months, 62 with CRT) were in the training set, and 116 (62 males, aged 15.00 [1.13, 156.00] months, 16 with CRT) were in the validation set. Multivariate logistic regression showed that a catheter time of 0-3 days (OR = 0.201, 95%CI: 0.081-0.497, P = 0.001), catheter time of 4-7 days (OR = 0.412, 95%CI: 0.176-0.964, P = 0.041), male (OR = 3.976, 95%CI: 1.864-4.483, P < 0.001), congenital heart diseases (OR = 0.277, 95%CI: 0.078-0.987, P = 0.048), postoperative (OR = 0.161, 95%CI: 0.072-0.360, P < 0.001), and femoral CVC (OR = 2.451, 95%CI: 1.129-5.318, P = 0.002) were independently associated with CRT. The nomogram incorporating these variables showed relatively good discrimination (AUC = 0.77, 95%CI: [0.65, 0.90]) and calibration abilities in the validation set, and the decision curve analysis (DCA) yielded a clinical net benefit.</p><p><strong>Conclusion: </strong>A prediction model for CRT in children with CVC was established based on catheter time, sex, diseases, postoperative, and catheter vein. The nomogram based on logistic regression model showed favorable predictive performance.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of iron supplementation in preterm infants at different gestational ages. 不同胎龄早产儿补铁的效果。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-20 DOI: 10.1186/s12887-024-04996-5
Sufeng Ruan, Jinrong Li, Fei Xiong, Di Qie, You Lu, Sufei Yang, Zhanghui Tang, Fan Yang

Background: Iron deficiency (ID) is the most prevalent nutritional deficiency disease in preterm infants, significantly affecting their growth and development. For preterm infants to flourish physically and neurologically, timely iron supplementation is essential. The main goals of this study were to determine whether the present iron supplementation regimen results in iron overload in late preterm infants and whether it can meet the growth requirements of early preterm infants for catch-up.

Methods: We conducted a prospective follow-up study on preterm infants at the Department of Child Health, West China Second University Hospital, Sichuan University, from January 1, 2020, to August 31, 2020. In this study, 177 preterm infants were divided into two groups based on gestational age-early preterm infants (gestational age < 34 weeks) and late preterm infants (gestational age ≥ 34 weeks and < 37 weeks)-to compare the incidence of iron deficiency, iron status, and physical growth of preterm infants receiving iron supplements (2-4 mg/kg/d).

Results: Iron supplementation considerably reduced the incidence of iron deficiency in preterm infants. The prevalence of iron deficiency in early preterm infants and late preterm infants was 11.3% and 5.1%, respectively, at the corrected gestational age of 3 months; at the corrected gestational age of 6 months, the prevalence was 5.3% and 6.3%, respectively. No preterm infants with iron deficiency were detected in either group at the corrected gestational age of 12 months. Ferritin was substantially lower in early preterm infants (36.87 ± 31.57 ng/ml) than in late preterm infants (65.78 ± 75.76 ng/ml) at the corrected gestational age of 3 months (p < 0.05). A multifactorial regression analysis of factors influencing iron metabolism levels in preterm infants revealed a positive relationship between log10hepcidin, birth weight, and ferritin, with higher birth weights resulting in higher ferritin levels.

Conclusions: Postnatal iron supplementation at 2-4 mg/kg/d in preterm infants significantly decreases the incidence of ID. There were substantial differences in iron levels across preterm infants of varying gestational ages. A tailored iron supplementation plan based on growth, birth weight, and gestational age may be a more suitable route for iron supplementation. Although the current study found that the postnatal iron status of early preterm infants differed from that of late preterm infants, the actual mechanism of action remains unknown, and large-sample, multicenter clinical studies are required to investigate this further.

背景:铁缺乏症(ID)是早产儿最常见的营养缺乏疾病,严重影响他们的生长发育。早产儿要想在身体和神经方面茁壮成长,及时补充铁元素至关重要。本研究的主要目的是确定目前的补铁方案是否会导致晚期早产儿铁过量,以及是否能满足早期早产儿的追赶性生长需求:2020年1月1日至2020年8月31日,我们在四川大学华西第二医院儿童保健科对早产儿进行了前瞻性随访研究。该研究根据胎龄将 177 名早产儿分为两组,即早产儿组(胎龄结果)和早产儿组(胎龄结果):补铁大大降低了早产儿缺铁的发生率。矫正胎龄为 3 个月的早产儿和晚期早产儿的缺铁发生率分别为 11.3% 和 5.1%;矫正胎龄为 6 个月的早产儿和晚期早产儿的缺铁发生率分别为 5.3% 和 6.3%。在 12 个月校正胎龄时,两组均未发现早产儿缺铁。早产儿的铁蛋白(36.87 ± 31.57 ng/ml)大大低于校正胎龄为 3 个月的晚期早产儿(65.78 ± 75.76 ng/ml)(p 10 血钙素、出生体重和铁蛋白,出生体重越高,铁蛋白水平越高):结论:早产儿出生后补充 2-4 mg/kg/d 的铁可显著降低 ID 的发病率。不同胎龄的早产儿的铁含量存在很大差异。根据生长情况、出生体重和胎龄制定有针对性的补铁计划可能是更合适的补铁途径。尽管目前的研究发现早产儿与晚期早产儿的产后铁状况不同,但实际的作用机制仍不清楚,需要进行大样本、多中心临床研究来进一步探究。
{"title":"The effect of iron supplementation in preterm infants at different gestational ages.","authors":"Sufeng Ruan, Jinrong Li, Fei Xiong, Di Qie, You Lu, Sufei Yang, Zhanghui Tang, Fan Yang","doi":"10.1186/s12887-024-04996-5","DOIUrl":"10.1186/s12887-024-04996-5","url":null,"abstract":"<p><strong>Background: </strong>Iron deficiency (ID) is the most prevalent nutritional deficiency disease in preterm infants, significantly affecting their growth and development. For preterm infants to flourish physically and neurologically, timely iron supplementation is essential. The main goals of this study were to determine whether the present iron supplementation regimen results in iron overload in late preterm infants and whether it can meet the growth requirements of early preterm infants for catch-up.</p><p><strong>Methods: </strong>We conducted a prospective follow-up study on preterm infants at the Department of Child Health, West China Second University Hospital, Sichuan University, from January 1, 2020, to August 31, 2020. In this study, 177 preterm infants were divided into two groups based on gestational age-early preterm infants (gestational age < 34 weeks) and late preterm infants (gestational age ≥ 34 weeks and < 37 weeks)-to compare the incidence of iron deficiency, iron status, and physical growth of preterm infants receiving iron supplements (2-4 mg/kg/d).</p><p><strong>Results: </strong>Iron supplementation considerably reduced the incidence of iron deficiency in preterm infants. The prevalence of iron deficiency in early preterm infants and late preterm infants was 11.3% and 5.1%, respectively, at the corrected gestational age of 3 months; at the corrected gestational age of 6 months, the prevalence was 5.3% and 6.3%, respectively. No preterm infants with iron deficiency were detected in either group at the corrected gestational age of 12 months. Ferritin was substantially lower in early preterm infants (36.87 ± 31.57 ng/ml) than in late preterm infants (65.78 ± 75.76 ng/ml) at the corrected gestational age of 3 months (p < 0.05). A multifactorial regression analysis of factors influencing iron metabolism levels in preterm infants revealed a positive relationship between log<sub>10</sub>hepcidin, birth weight, and ferritin, with higher birth weights resulting in higher ferritin levels.</p><p><strong>Conclusions: </strong>Postnatal iron supplementation at 2-4 mg/kg/d in preterm infants significantly decreases the incidence of ID. There were substantial differences in iron levels across preterm infants of varying gestational ages. A tailored iron supplementation plan based on growth, birth weight, and gestational age may be a more suitable route for iron supplementation. Although the current study found that the postnatal iron status of early preterm infants differed from that of late preterm infants, the actual mechanism of action remains unknown, and large-sample, multicenter clinical studies are required to investigate this further.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent de novo MACF1 mutation and inherited 16p13.11 microduplication in a preterm newborn with hypotonia, joint hyperlaxity and multiple congenital malformations: a case report. 一例早产新生儿并发新发 MACF1 基因突变和遗传性 16p13.11 微重复:肌张力低下、关节过度松弛和多发性先天畸形的病例报告。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-16 DOI: 10.1186/s12887-024-04628-y
Lanlan Mi, Ruen Yao, Weiwei Guo, Jian Wang, Guoqing Zhang, Xiuxia Ye

Background: The MACF1 gene, found on chromosome 1p34.3, is vital for controlling cytoskeleton dynamics, cell movement, growth, and differentiation. It consists of 101 exons, spanning over 270 kb. The 16p13.11 microduplication syndrome results from the duplication of 16p13.11 chromosome copies and is associated with various neurodevelopmental and physiological abnormalities. Both MACF1 and 16p13.11 microduplication have significant impacts on neural development, potentially leading to nerve damage or neurological diseases. This study presents a unique case of a patient simultaneously experiencing a de novo MACF1 mutation and a hereditary 16p13.11 microduplication, which has not been reported previously.

Case presentation: In this report, we describe a Chinese preterm newborn girl exhibiting the typical characteristics of 16.13.11 microduplication syndrome. These features include developmental delay, respiratory issues, feeding problems, muscle weakness, excessive joint movement, and multiple congenital abnormalities. Through whole-exome sequencing, we identified a disease-causing mutation in the MACF1 gene (c.15266T > C / p. Met5089Thr). Additionally, after microarray analysis, we confirmed the presence of a 16p13.11 microduplication (chr16:14,916,289 - 16,315,688), which was inherited from the mother.

Conclusions: The patient's clinical presentation, marked by muscle weakness and multiple birth defects, may be attributed to both the de novo MACF1 mutation and the 16p13.11 duplication, which could have further amplified her severe symptoms. Genetic testing for individuals with complex clinical manifestations can offer valuable insights for diagnosis and serve as a reference for genetic counseling for both patients and their families.

背景:MACF1 基因位于染色体 1p34.3,对控制细胞骨架动力学、细胞运动、生长和分化至关重要。它由 101 个外显子组成,跨度超过 270 kb。16p13.11 微重复综合征是由 16p13.11 染色体拷贝的重复造成的,与各种神经发育和生理异常有关。MACF1 和 16p13.11 微重复都对神经发育有重大影响,可能导致神经损伤或神经系统疾病。本研究介绍了一例同时患有新发 MACF1 突变和遗传性 16p13.11 微重复的独特病例,该病例此前从未报道过:在本报告中,我们描述了一名中国早产新生女婴,她表现出 16.13.11 微重复综合征的典型特征。这些特征包括发育迟缓、呼吸问题、喂养问题、肌无力、关节活动过度以及多种先天性畸形。通过全外显子组测序,我们确定了 MACF1 基因的致病突变(c.15266T > C / p. Met5089Thr)。此外,经过微阵列分析,我们确认了患者存在一个 16p13.11 微重复(chr16:14,916,289 - 16,315,688),该基因遗传自母亲:结论:该患者的临床表现以肌无力和多种先天缺陷为特征,这可能与 MACF1 基因突变和 16p13.11 重合有关,后者可能会进一步加重她的严重症状。对具有复杂临床表现的个体进行基因检测,可为诊断提供有价值的见解,并为患者及其家属的遗传咨询提供参考。
{"title":"Concurrent de novo MACF1 mutation and inherited 16p13.11 microduplication in a preterm newborn with hypotonia, joint hyperlaxity and multiple congenital malformations: a case report.","authors":"Lanlan Mi, Ruen Yao, Weiwei Guo, Jian Wang, Guoqing Zhang, Xiuxia Ye","doi":"10.1186/s12887-024-04628-y","DOIUrl":"10.1186/s12887-024-04628-y","url":null,"abstract":"<p><strong>Background: </strong>The MACF1 gene, found on chromosome 1p34.3, is vital for controlling cytoskeleton dynamics, cell movement, growth, and differentiation. It consists of 101 exons, spanning over 270 kb. The 16p13.11 microduplication syndrome results from the duplication of 16p13.11 chromosome copies and is associated with various neurodevelopmental and physiological abnormalities. Both MACF1 and 16p13.11 microduplication have significant impacts on neural development, potentially leading to nerve damage or neurological diseases. This study presents a unique case of a patient simultaneously experiencing a de novo MACF1 mutation and a hereditary 16p13.11 microduplication, which has not been reported previously.</p><p><strong>Case presentation: </strong>In this report, we describe a Chinese preterm newborn girl exhibiting the typical characteristics of 16.13.11 microduplication syndrome. These features include developmental delay, respiratory issues, feeding problems, muscle weakness, excessive joint movement, and multiple congenital abnormalities. Through whole-exome sequencing, we identified a disease-causing mutation in the MACF1 gene (c.15266T > C / p. Met5089Thr). Additionally, after microarray analysis, we confirmed the presence of a 16p13.11 microduplication (chr16:14,916,289 - 16,315,688), which was inherited from the mother.</p><p><strong>Conclusions: </strong>The patient's clinical presentation, marked by muscle weakness and multiple birth defects, may be attributed to both the de novo MACF1 mutation and the 16p13.11 duplication, which could have further amplified her severe symptoms. Genetic testing for individuals with complex clinical manifestations can offer valuable insights for diagnosis and serve as a reference for genetic counseling for both patients and their families.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful treatment of Enterococcus gallinarum infection in a neonate with vancomycin: a case report. 用万古霉素成功治疗新生儿胆肠球菌感染:病例报告。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-15 DOI: 10.1186/s12887-024-05004-6
Liangjie Hao, Han Wang

Background: Enterococcus gallinarum (EG) is typically found in the gastrointestinal tracts of birds and mammals. Although its strains are rarely isolated from clinical specimens, EG can lead to septicemia in immunocompromised individuals. EG infections are uncommon in household settings, but their incidence has been rising due to increased antibiotic usage and invasive treatments, particularly in Neonatal Intensive Care Units (NICUs). EG inherently exhibits resistance to vancomycin but is highly sensitive to linezolid. Despite showing in vitro resistance, vancomycin has shown clinical efficacy in treating EG meningitis.

Case presentation: A neonate born at 30 + 2 weeks gestation was admitted to the Neonatal Intensive Care Unit (NICU) after EG was detected in blood and cerebrospinal fluid cultures. Susceptibility testing indicated that the bacterial strain was resistant to vancomycin and sensitive to linezolid. Initially, vancomycin was selected for treatment. However, due to persistent EG cultures in the blood and cerebrospinal fluid, the treatment was adjusted to linezolid. This led to a rapid decrease in platelet (PLT) count, suspected to be an adverse reaction. Concurrently, the patient experienced recurrent fever and elevated inflammatory marker levels, prompting the discontinuation of linezolid and a return to vancomycin. Subsequent administration of vancomycin stabilized the patient's condition, as evidenced by improved C-reactive protein (CRP), procalcitonin (PCT), and cerebrospinal fluid parameters, ultimately leading to discharge after an eight-week treatment period.

Conclusion: This retrospective analysis highlights the efficacy of vancomycin in treating EG infections, suggesting that specific genetic phenotypes may influence treatment sensitivity. Monitoring vancomycin blood levels is crucial for determining treatment effectiveness.

背景:胆肠球菌(EG)通常存在于鸟类和哺乳动物的胃肠道中。虽然很少从临床标本中分离出其菌株,但 EG 可导致免疫力低下的人发生败血症。EG 感染在家庭环境中并不常见,但由于抗生素使用和侵入性治疗的增加,特别是在新生儿重症监护室(NICU)中,其发病率一直在上升。EG 本身对万古霉素有耐药性,但对利奈唑胺高度敏感。尽管出现体外耐药性,但万古霉素在治疗 EG 脑膜炎方面仍有临床疗效:一名妊娠 30+2 周的新生儿在血液和脑脊液培养中检测到 EG,随后被送入新生儿重症监护室(NICU)。药敏试验显示,该细菌菌株对万古霉素耐药,对利奈唑胺敏感。最初选择万古霉素进行治疗。然而,由于血液和脑脊液中持续存在 EG 培养物,治疗方法调整为利奈唑胺。这导致血小板(PLT)计数迅速下降,怀疑是不良反应。与此同时,患者出现反复发热和炎症标志物水平升高,促使患者停用利奈唑胺,重新使用万古霉素。随后服用万古霉素后,患者病情趋于稳定,C反应蛋白(CRP)、降钙素原(PCT)和脑脊液指标均有所改善,最终在治疗八周后出院:这项回顾性分析强调了万古霉素治疗 EG 感染的疗效,表明特定的基因表型可能会影响治疗的敏感性。监测万古霉素的血药浓度对于确定治疗效果至关重要。
{"title":"Successful treatment of Enterococcus gallinarum infection in a neonate with vancomycin: a case report.","authors":"Liangjie Hao, Han Wang","doi":"10.1186/s12887-024-05004-6","DOIUrl":"10.1186/s12887-024-05004-6","url":null,"abstract":"<p><strong>Background: </strong>Enterococcus gallinarum (EG) is typically found in the gastrointestinal tracts of birds and mammals. Although its strains are rarely isolated from clinical specimens, EG can lead to septicemia in immunocompromised individuals. EG infections are uncommon in household settings, but their incidence has been rising due to increased antibiotic usage and invasive treatments, particularly in Neonatal Intensive Care Units (NICUs). EG inherently exhibits resistance to vancomycin but is highly sensitive to linezolid. Despite showing in vitro resistance, vancomycin has shown clinical efficacy in treating EG meningitis.</p><p><strong>Case presentation: </strong>A neonate born at 30 + 2 weeks gestation was admitted to the Neonatal Intensive Care Unit (NICU) after EG was detected in blood and cerebrospinal fluid cultures. Susceptibility testing indicated that the bacterial strain was resistant to vancomycin and sensitive to linezolid. Initially, vancomycin was selected for treatment. However, due to persistent EG cultures in the blood and cerebrospinal fluid, the treatment was adjusted to linezolid. This led to a rapid decrease in platelet (PLT) count, suspected to be an adverse reaction. Concurrently, the patient experienced recurrent fever and elevated inflammatory marker levels, prompting the discontinuation of linezolid and a return to vancomycin. Subsequent administration of vancomycin stabilized the patient's condition, as evidenced by improved C-reactive protein (CRP), procalcitonin (PCT), and cerebrospinal fluid parameters, ultimately leading to discharge after an eight-week treatment period.</p><p><strong>Conclusion: </strong>This retrospective analysis highlights the efficacy of vancomycin in treating EG infections, suggesting that specific genetic phenotypes may influence treatment sensitivity. Monitoring vancomycin blood levels is crucial for determining treatment effectiveness.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between maternal bacteremia during the peripartum period and early-onset neonatal sepsis: a retrospective cohort study. 围产期母体菌血症与新生儿早期败血症之间的关系:一项回顾性队列研究。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-15 DOI: 10.1186/s12887-024-04980-z
Ashraf Gad, Mahmoud Alkhdr, Rayan Terkawi, Hafsa Alsharif, Marwa Ibrahim, Rasha Amin, Elmunzir Algibali, Prem Chandra, Manal Hamed, Hawabibee Mahir Petkar, Mohammad A A Bayoumi

Introduction: Early-onset neonatal sepsis (EONS) significantly impacts neonatal morbidity and mortality, with maternal bacteremia during the peripartum period being a potential risk factor. This study aims to explore the association between peripartum maternal bacteremia and EONS.

Methods: A retrospective cohort study at the Women's Wellness and Research Center in Doha, Qatar (2015-2019) compared women with and without bacteremia, based on blood cultures taken from up to seven days before to 48 h after delivery, examining the association with EONS.

Results: Among the 536 maternal blood cultures analyzed, 102 (19.0%) were positive. The most prevalent organisms were Group B streptococcus (GBS) (39.2%), followed by Escherichia coli (14.7%) and anaerobes (10.8%). Neonates from bacteremic mothers had lower birth weights (2913 ± 86 g vs. 3140 ± 745 g; MD 227.63 g; 95% CI 61.72 - 393.55; p = 0.007), required more resuscitation (27.5% vs. 13.2%; OR 2.48; 95% CI 1.48 - 4.17; p < 0.001), and received antibiotics for ≥ 7 days more frequently (41.2% vs. 16.6%; OR 3.51; 95% CI 2.20 - 5.62; p < 0.001) compared to those from non-bacteremic mothers. Maternal Gram-positive (GP) organisms were more commonly isolated in term gestation (67.9%) compared to Gram-negative (GN) (22.2%) and anaerobic bacteremias (9.9%). During intrapartum, GP bacteremia was predominant (67.1%) vs. GN (21.4%) and Anaerobes (11.4%), with GN bacteremia being more common in postpartum samples. Culture-proven EONS occurred in 0.75% of the cohort, affecting 3.9% of infants from bacteremic mothers vs. none in controls (OR 2.34; 95% CI 1.27 - 4.31; p < 0.001). Culture-negative EONS appeared in 14.7% of infants from bacteremic mothers vs. 7.8% in controls (OR 2.02; 95% CI, 1.05 - 3.88; p = 0.03). Among 40 cases of maternal GBS bacteremia, culture-proven GBS EONS occurred in 3 neonates (7.5%), all from mothers with negative GBS screening, compared to none in the control group. A strong association was found between EONS and maternal bacteremia due to any organism (aOR 2.34; 95% CI, 1.24 - 4.41; p = 0.009), GP bacteremia (aOR 3.66; 95% CI, 1.82 - 7.34; p < 0.001), or GBS (aOR 5.74; 95% CI, 2.57 - 12.81; p < 0.001). Bacteremia due to GN and Anaerobic organisms were not associated with EONS. Chorioamnionitis and antepartum fever were independent predictors for EONS associated with significant bacterial isolates.

Conclusion: This study underscores the significant impact of maternal GP bacteremia, particularly from GBS, on EONS. The strong association highlights the need for vigilant monitoring and interventions in pregnancies complicated by bacteremia to reduce adverse neonatal outcomes.

导言:早发型新生儿败血症(EONS)严重影响新生儿的发病率和死亡率,而围产期产妇菌血症是一个潜在的风险因素。本研究旨在探讨围产期产妇菌血症与新生儿败血症之间的关系:卡塔尔多哈妇女健康与研究中心开展了一项回顾性队列研究(2015-2019 年),根据分娩前 7 天至分娩后 48 小时的血液培养结果,比较了有菌血症和无菌血症的产妇,研究其与 EONS 的关联:在分析的 536 份产妇血培养中,有 102 份(19.0%)呈阳性。最常见的细菌是乙型链球菌(GBS)(39.2%),其次是大肠杆菌(14.7%)和厌氧菌(10.8%)。来自菌血症母亲的新生儿出生体重较轻(2913 ± 86 g vs. 3140 ± 745 g; MD 227.63 g; 95% CI 61.72 - 393.55; p = 0.007),需要更多的复苏治疗(27.5% vs. 13.2%; OR 2.48; 95% CI 1.48 - 4.17; p 结论:本研究强调了孕产妇 GP 菌血症(尤其是 GBS)对 EONS 的重大影响。这种强烈的关联性凸显了对菌血症并发妊娠进行警惕性监测和干预以减少新生儿不良结局的必要性。
{"title":"Associations between maternal bacteremia during the peripartum period and early-onset neonatal sepsis: a retrospective cohort study.","authors":"Ashraf Gad, Mahmoud Alkhdr, Rayan Terkawi, Hafsa Alsharif, Marwa Ibrahim, Rasha Amin, Elmunzir Algibali, Prem Chandra, Manal Hamed, Hawabibee Mahir Petkar, Mohammad A A Bayoumi","doi":"10.1186/s12887-024-04980-z","DOIUrl":"10.1186/s12887-024-04980-z","url":null,"abstract":"<p><strong>Introduction: </strong>Early-onset neonatal sepsis (EONS) significantly impacts neonatal morbidity and mortality, with maternal bacteremia during the peripartum period being a potential risk factor. This study aims to explore the association between peripartum maternal bacteremia and EONS.</p><p><strong>Methods: </strong>A retrospective cohort study at the Women's Wellness and Research Center in Doha, Qatar (2015-2019) compared women with and without bacteremia, based on blood cultures taken from up to seven days before to 48 h after delivery, examining the association with EONS.</p><p><strong>Results: </strong>Among the 536 maternal blood cultures analyzed, 102 (19.0%) were positive. The most prevalent organisms were Group B streptococcus (GBS) (39.2%), followed by Escherichia coli (14.7%) and anaerobes (10.8%). Neonates from bacteremic mothers had lower birth weights (2913 ± 86 g vs. 3140 ± 745 g; MD 227.63 g; 95% CI 61.72 - 393.55; p = 0.007), required more resuscitation (27.5% vs. 13.2%; OR 2.48; 95% CI 1.48 - 4.17; p < 0.001), and received antibiotics for ≥ 7 days more frequently (41.2% vs. 16.6%; OR 3.51; 95% CI 2.20 - 5.62; p < 0.001) compared to those from non-bacteremic mothers. Maternal Gram-positive (GP) organisms were more commonly isolated in term gestation (67.9%) compared to Gram-negative (GN) (22.2%) and anaerobic bacteremias (9.9%). During intrapartum, GP bacteremia was predominant (67.1%) vs. GN (21.4%) and Anaerobes (11.4%), with GN bacteremia being more common in postpartum samples. Culture-proven EONS occurred in 0.75% of the cohort, affecting 3.9% of infants from bacteremic mothers vs. none in controls (OR 2.34; 95% CI 1.27 - 4.31; p < 0.001). Culture-negative EONS appeared in 14.7% of infants from bacteremic mothers vs. 7.8% in controls (OR 2.02; 95% CI, 1.05 - 3.88; p = 0.03). Among 40 cases of maternal GBS bacteremia, culture-proven GBS EONS occurred in 3 neonates (7.5%), all from mothers with negative GBS screening, compared to none in the control group. A strong association was found between EONS and maternal bacteremia due to any organism (aOR 2.34; 95% CI, 1.24 - 4.41; p = 0.009), GP bacteremia (aOR 3.66; 95% CI, 1.82 - 7.34; p < 0.001), or GBS (aOR 5.74; 95% CI, 2.57 - 12.81; p < 0.001). Bacteremia due to GN and Anaerobic organisms were not associated with EONS. Chorioamnionitis and antepartum fever were independent predictors for EONS associated with significant bacterial isolates.</p><p><strong>Conclusion: </strong>This study underscores the significant impact of maternal GP bacteremia, particularly from GBS, on EONS. The strong association highlights the need for vigilant monitoring and interventions in pregnancies complicated by bacteremia to reduce adverse neonatal outcomes.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11325601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tubal mesosalpinx cysts combined with adnexal torsion in adolescents: a report of two cases and review of the literature. 青少年输卵管间质部囊肿合并附件扭转:两例病例报告及文献综述。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-14 DOI: 10.1186/s12887-024-05001-9
Junzhuo Chen, Changjun Li, He Zhang, Dongqi Li, Wei Wang

Background: Tubal mesosalpinx cysts are paratubal cysts, that account for approximately 10% of adnexal masses, and the presence of these cysts combined with adnexal torsion is a rare acute abdominal condition, with few cases reported in the literature. We reported two cases of adolescent tubal mesosalpinx cysts combined with adnexal torsion and reviewed the literature to help improve the diagnosis of the disease.

Case reports: The first patient was an 11-year-old girl with left lower abdominal pain for 5 days and fever with nausea and vomiting for 3 days, who was found to have a cystic pelvic mass on preoperative imaging and was diagnosed intraoperatively and postoperatively on pathology as having a left tubal mesosalpinx cyst combined with adnexal torsion. The second patient was a 13-year-old girl with right lower abdominal pain for 16 h and a palpable mass in the lower and middle abdomen on examination, which was hard and tender to palpate. Preoperative imaging revealed a large cystic mass in the right adnexal region, and intraoperative and postoperative pathology revealed a right tubal mesosalpinx cyst combined with adnexal torsion.

Conclusions: Tubal mesosalpinx cysts combined with adnexal torsion are rare causes of acute lower abdominal pain. Early diagnosis and timely surgery are necessary to ensure ovarian and tubal function. Accurate preoperative imaging diagnosis is challenging, and MRI is a beneficial supplement to ultrasound and CT examinations, providing more objective imaging information and reducing the incidence of adverse outcomes.

背景:输卵管间质部囊肿是一种输卵管旁囊肿,约占附件肿块的10%,这种囊肿合并附件扭转是一种罕见的急腹症,文献中鲜有报道。我们报告了两例青少年输卵管间质部囊肿合并附件扭转的病例,并回顾了相关文献,希望有助于提高该病的诊断水平:第一例患者是一名11岁女孩,左下腹痛5天,发热伴恶心呕吐3天,术前造影发现盆腔囊性肿块,术中和术后病理诊断为左侧输卵管间质部囊肿合并附件扭转。第二例患者是一名13岁女孩,右下腹疼痛16小时,检查时在中下腹部可触及肿块,触诊时肿块质硬且有压痛。术前造影显示右侧附件区有一巨大囊性肿块,术中和术后病理显示为右侧输卵管间质部囊肿合并附件扭转:结论:输卵管间质部囊肿合并附件扭转是导致急性下腹痛的罕见原因。早期诊断和及时手术对确保卵巢和输卵管功能十分必要。术前准确的影像学诊断具有挑战性,磁共振成像是超声波和 CT 检查的有益补充,可提供更客观的影像学信息,降低不良后果的发生率。
{"title":"Tubal mesosalpinx cysts combined with adnexal torsion in adolescents: a report of two cases and review of the literature.","authors":"Junzhuo Chen, Changjun Li, He Zhang, Dongqi Li, Wei Wang","doi":"10.1186/s12887-024-05001-9","DOIUrl":"10.1186/s12887-024-05001-9","url":null,"abstract":"<p><strong>Background: </strong>Tubal mesosalpinx cysts are paratubal cysts, that account for approximately 10% of adnexal masses, and the presence of these cysts combined with adnexal torsion is a rare acute abdominal condition, with few cases reported in the literature. We reported two cases of adolescent tubal mesosalpinx cysts combined with adnexal torsion and reviewed the literature to help improve the diagnosis of the disease.</p><p><strong>Case reports: </strong>The first patient was an 11-year-old girl with left lower abdominal pain for 5 days and fever with nausea and vomiting for 3 days, who was found to have a cystic pelvic mass on preoperative imaging and was diagnosed intraoperatively and postoperatively on pathology as having a left tubal mesosalpinx cyst combined with adnexal torsion. The second patient was a 13-year-old girl with right lower abdominal pain for 16 h and a palpable mass in the lower and middle abdomen on examination, which was hard and tender to palpate. Preoperative imaging revealed a large cystic mass in the right adnexal region, and intraoperative and postoperative pathology revealed a right tubal mesosalpinx cyst combined with adnexal torsion.</p><p><strong>Conclusions: </strong>Tubal mesosalpinx cysts combined with adnexal torsion are rare causes of acute lower abdominal pain. Early diagnosis and timely surgery are necessary to ensure ovarian and tubal function. Accurate preoperative imaging diagnosis is challenging, and MRI is a beneficial supplement to ultrasound and CT examinations, providing more objective imaging information and reducing the incidence of adverse outcomes.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trend, and multivariate decomposition of perinatal mortality in Ethiopia using further analysis of EDHS 2005-2016. 利用对 2005-2016 年埃塞俄比亚人口与健康调查的进一步分析,对埃塞俄比亚围产期死亡率的趋势和多变量分解进行分析。
IF 2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-08-13 DOI: 10.1186/s12887-024-04998-3
Muluken Chanie Agimas, Demewoz Kefale, Tigabu Kidie Tesfie, Worku Necho, Tigabu Munye, Gedefaw Abeje, Yohannes Tesfahun, Amare Simegn, Amare Kassaw, Shegaw Zeleke, Solomon Demis, Habtamu Shimels Hailemeskel

Background: Perinatal mortality is a global health problem, especially in Ethiopia, which has the highest perinatal mortality rate. Studies about perinatal mortality were conducted in Ethiopia, but which factors specifically contribute to the change in perinatal mortality across time is unknown.

Objectives: To assess the trend and multivariate decomposition of perinatal mortality in Ethiopia using EDHS 2005-2016.

Methods: A community-based, cross-sectional study design was used. EDHS 2005-2016 data was used, and weighting has been applied to adjust the difference in the probability of selection. Logit-based multivariate decomposition analysis was used using STATA version 14.1. The best model was selected using the lowest AIC value, and variables were selected with a p-value less than 0.05 at 95% CI.

Result: The trend of perinatal mortality in Ethiopia decreased from 37 per 1000 births in 2005 to 33 per 1000 births in 2016. About 83.3% of the decrease in perinatal mortality in the survey was attributed to the difference in the endowment (composition) of the women. Among the differences in the endowment, the difference in the composition of ANC visits, taking the TT vaccine, urban residence, occupation, secondary education, and birth attendant significantly decreased perinatal mortality in the last 10 years. Among the differences in coefficients, skilled birth attendants significantly decreased perinatal mortality.

Conclusion and recommendation: The perinatal mortality rate in Ethiopia has declined over time. Variables like ANC visits, taking the TT vaccine, urban residence, occupation, secondary education, and skilled birth attendants reduce perinatal mortality. To reduce perinatal mortality more, scaling up maternal and newborn health services has a critical role.

背景:围产期死亡率是一个全球性的健康问题,尤其是在围产期死亡率最高的埃塞俄比亚。埃塞俄比亚对围产期死亡率进行了研究,但围产期死亡率随时间变化的具体因素尚不清楚:利用 2005-2016 年埃塞俄比亚人口与健康调查(EDHS)评估埃塞俄比亚围产期死亡率的趋势和多变量分解:方法:采用基于社区的横断面研究设计。方法:采用基于社区的横断面研究设计,使用 EDHS 2005-2016 年数据,并应用加权法调整选择概率的差异。使用 STATA 14.1 版进行基于 Logit 的多元分解分析。使用最低 AIC 值选择最佳模型,并选择在 95% CI 下 p 值小于 0.05 的变量:埃塞俄比亚围产期死亡率呈下降趋势,从 2005 年的每千名新生儿 37 例降至 2016 年的每千名新生儿 33 例。调查中围产期死亡率下降的约 83.3% 归因于妇女禀赋(构成)的差异。在禀赋差异中,产前检查、接种百白破疫苗、城市居住、职业、中等教育和助产士的构成差异显著降低了过去 10 年的围产儿死亡率。在系数差异中,熟练的助产士能明显降低围产期死亡率:埃塞俄比亚的围产期死亡率随着时间的推移有所下降。产前检查、接种 TT 疫苗、城市居民、职业、中等教育和熟练助产士等变量降低了围产期死亡率。要进一步降低围产期死亡率,加强孕产妇和新生儿保健服务至关重要。
{"title":"Trend, and multivariate decomposition of perinatal mortality in Ethiopia using further analysis of EDHS 2005-2016.","authors":"Muluken Chanie Agimas, Demewoz Kefale, Tigabu Kidie Tesfie, Worku Necho, Tigabu Munye, Gedefaw Abeje, Yohannes Tesfahun, Amare Simegn, Amare Kassaw, Shegaw Zeleke, Solomon Demis, Habtamu Shimels Hailemeskel","doi":"10.1186/s12887-024-04998-3","DOIUrl":"10.1186/s12887-024-04998-3","url":null,"abstract":"<p><strong>Background: </strong>Perinatal mortality is a global health problem, especially in Ethiopia, which has the highest perinatal mortality rate. Studies about perinatal mortality were conducted in Ethiopia, but which factors specifically contribute to the change in perinatal mortality across time is unknown.</p><p><strong>Objectives: </strong>To assess the trend and multivariate decomposition of perinatal mortality in Ethiopia using EDHS 2005-2016.</p><p><strong>Methods: </strong>A community-based, cross-sectional study design was used. EDHS 2005-2016 data was used, and weighting has been applied to adjust the difference in the probability of selection. Logit-based multivariate decomposition analysis was used using STATA version 14.1. The best model was selected using the lowest AIC value, and variables were selected with a p-value less than 0.05 at 95% CI.</p><p><strong>Result: </strong>The trend of perinatal mortality in Ethiopia decreased from 37 per 1000 births in 2005 to 33 per 1000 births in 2016. About 83.3% of the decrease in perinatal mortality in the survey was attributed to the difference in the endowment (composition) of the women. Among the differences in the endowment, the difference in the composition of ANC visits, taking the TT vaccine, urban residence, occupation, secondary education, and birth attendant significantly decreased perinatal mortality in the last 10 years. Among the differences in coefficients, skilled birth attendants significantly decreased perinatal mortality.</p><p><strong>Conclusion and recommendation: </strong>The perinatal mortality rate in Ethiopia has declined over time. Variables like ANC visits, taking the TT vaccine, urban residence, occupation, secondary education, and skilled birth attendants reduce perinatal mortality. To reduce perinatal mortality more, scaling up maternal and newborn health services has a critical role.</p>","PeriodicalId":9144,"journal":{"name":"BMC Pediatrics","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141975135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1